" IMO this perhaps shows we have displayed some efficacy, otherwise why set up a sub trial? must have had at least some effect no? And what of the other subjects? no progression noted?"
My thoughts exactly...hopefully hear more about it at the shareholders brief.
2b trial variation-safety profile assessment, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.010(2.47%) |
Mkt cap ! $573.7M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.8¢ | 39.0¢ | $1.291M | 3.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 160217 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 119125 | 4 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |